Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.50), $0.18 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $122.2 million versus the consensus estimate of $127.37 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.